Ariadne Labs said on Thursday that the Global Mass Vaccination Site Collaborative has expanded its effort to support mass vaccination sites in low- and middle-income countries under a funding agreement with the Bill & Melinda Gates Foundation.

The Collaborative announced an open access website to provide one-stop resource for curated tools, programming and support for establishing and maintaining mass vaccination sites and other vaccination efforts. The resources include vaccination site playbooks and access to peer support through a vaccine site operators within the Boost Community, an initiative of the Sabin Vaccine Institute.

Additionally, the Collaborative hosts biweekly meetings for immunization professionals worldwide to discuss operational aspects of mass vaccination sites, share best practices across countries and communities and support countries just beginning their mass vaccination work.

To date, the Collaborative has hosted more than 30 webinars and about 20 organizations and agencies have given presentations on vaccination efforts throughout the US and in Brazil, Ghana, Haiti, India and Côte d'Ivoire.

Global Mass Vaccination Site Collaborative is a joint initiative led by Ariadne Labs and the Sabin Vaccine Institute's Boost Community. Ariadne Labs is a joint centre for health systems innovation at Brigham and Women's Hospital and the Harvard T.H. Chan School of Public Health. The Boost community is a global network of more than 2,100 immunization professionals from 135 countries.